Out Licensing Dossiers

Out Licensing Dossiers
Product Description

  • Out Licensing
  • Technology Transfer
  • Co-Development / Profit Sharing with
               Technology Partners
               API partners
               Marketing Partners
               CMO Partners

Read more Show less

Aizant Drug Research Solutions Pvt. Ltd.

  • IN
  • 2015
    On CPHI since
  • 4
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Manufacturer/Innovator
Pharmaceutical company
Veterinary Company
Primary activities
Analytical Services
API Producer
Biopharmaceutical
Clinical Research
Contract Manufacturer
Contract Research Organisation
Out-licensing specialist
View company profile
Categories
more categories Show less
Specifications
  • Details
    • Global Dossier Out-Licensing
    • NCE-1, PIV, PIII/PII, 505b2
    • 13+ NCE-1 filings
    • Co-Development, Profit Share & Distribution Deals
    • 10+ products in pipeline for development
  • Selling Points
    Experienced Technicians; International Approvals/Standards; Quality Service; USFDA, EUGMP, MHRA, ANVISA, INVIMA, ANSM, SFDA, GCC< RUSSIA MOH, BELARUS, NPRA, TGA, SAPHRA, WHO GMP, ISO etc.,
  • Model
    Out Licensing Dossiers and Commercial Supplies/ Profit Share
  • Supplied from
    India
More specifications Fewer specifications
Sales Markets
Show more Show less

Aizant Drug Research Solutions Pvt. Ltd.

  • IN
  • 2015
    On CPHI since
  • 4
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Contract Service
Manufacturer/Innovator
Pharmaceutical company
Veterinary Company
Primary activities
Analytical Services
API Producer
Biopharmaceutical
Clinical Research
Contract Manufacturer
Contract Research Organisation
Out-licensing specialist
View company profile

More Products from Aizant Drug Research Solutions Pvt. Ltd. (4)

  • Clinical Research Organization (CRO)

    Product Clinical Research Organization (CRO)

    Capabilities:
    • 2 Clinical Pharmacological Units with 164 beds • 14 LCMS-MS machines • AB-SCIEX 5500 • ICPMS Services:
    • BA/BE Studies for Global Submissions • Patient PK studies • Clinical End Point Studies Volunteer Database:
    • Male 14,000+ • Female 3,000+ Access to Post Menopausal Wom...
  • Contract Formulation Development & Analytical Development (CDMO)

    Product Contract Formulation Development & Analytical Development (CDMO)

    Contract Research and Development (Fee for Service)
    Solids-
    • Tablet, Capsule, PFOS, Granules, Sachets, Pellets • Oncology Potent and Veterinary products • MR,ER,SR,DR,GR,PR Dual Release • Mini-Tablet in Capsule, MUPS, Hot Melt Extrusion Injectables • Liquid, Lyoph...
  • Contract Manufacturing Services (CMO)

    Product Contract Manufacturing Services (CMO)

    Contract Manufacturing

    (Oral Tablets and Capsules)

    Capacity

    Aizant’s advance manufacturing facilities are capable of handling 3 Billion units per annum (Tablets & Capsules, in both potent and general product manufacturing area)

    Packaging Capabilities
    qq...
  • Out Licensing Dossiers

    Product Out Licensing Dossiers

    • Out Licensing • Technology Transfer • Co-Development / Profit Sharing with •
    Technology Partners

    API partners

    Marketing Partners

    CMO Partners